Feeley Kevin 4

4 · GeneDx Holdings Corp. · Filed Jun 3, 2026

AI-generated summary of this filing

Updated Jun 3, 2026

GeneDx (WGS) CFO Kevin Feeley Sells 369 Shares

What Happened

Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp. (WGS), had 717 restricted stock units (RSUs) settle on June 1, 2026 (converted to 717 shares at $0.00 per share) and sold 369 shares in an open-market "sell-to-cover" transaction at $51.74 each, generating $19,092. The filings show both the RSU settlement (derivative exercise/conversion) and the open-market sale.

Key Details

Transaction date: June 1, 2026.
RSU settlement: 717 shares acquired upon conversion (exercise/conversion code M) at $0.00 (footnote F1: RSUs settle for no consideration).
Open-market sale: 369 shares disposed at $51.74 each, proceeds $19,092 (code S). Footnote F2: the sale was a sell-to-cover to satisfy tax withholding obligations and not a discretionary sale by the reporting person.
Additional derivative entry: 717 shares listed as disposed at $0.00 (reflecting RSU settlement/withholding mechanics).
Shares/holdings after the transaction (per filing): 35,290 shares of Class A common stock beneficially owned, plus RSUs representing rights to up to 91,702 shares and options to purchase up to 25,906 shares (footnote F3).
Vesting note: the RSU award vests quarterly at 6.25% per tranche with the first tranche vested Dec 1, 2022 (footnote F4).
Filing: reported on Form 4 filed June 3, 2026 (transactions dated June 1, 2026); no late-filing indication in the report.

Context

This activity appears to be a routine sell-to-cover tied to the automatic settlement of RSUs to satisfy tax withholding. The RSUs were converted/settled (no purchase price), and a portion of shares was sold rather than paid in cash for taxes. Such sell-to-cover transactions are common and do not necessarily indicate an executive view on the company’s stock price.

Form 4

Period: 2026-06-01

CHIEF FINANCIAL OFFICER

Transactions

Exercise/Conversion
Class A Common Stock
[F1]
2026-06-01+717→ 35,659 total
Sale
Class A Common Stock
[F2][F3]
2026-06-01$51.74/sh−369$19,092→ 35,290 total
Exercise/Conversion
Restricted Stock Unit
[F1][F4]
2026-06-01−717→ 717 total
→ Class A Common Stock (717 underlying)

Footnotes (4)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
[F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
[F3]Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 35,290 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate 91,702 shares of Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
[F4]6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

Signature

/s/ Bridget Brown, Attorney-in-Fact|2026-06-03

1 file